Balance Sheet
Cash Flow Statement
Amortization of GoodwillAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Legend Biotech (LEGN) Gains from Sales and Divestitures: 2020-2022

Historic Gains from Sales and Divestitures for Legend Biotech (LEGN) over the last 3 years, with Dec 2022 value amounting to $481,000.

  • Legend Biotech's Gains from Sales and Divestitures rose 12400.00% to $250,000 in Q2 2025 from the same period last year, while for Jun 2025 it was $250,000, marking a year-over-year increase of 12400.00%. This contributed to the annual value of $481,000 for FY2022, which is 50.62% down from last year.
  • Per Legend Biotech's latest filing, its Gains from Sales and Divestitures stood at $481,000 for FY2022, which was down 50.62% from $974,000 recorded in FY2021.
  • Over the past 5 years, Legend Biotech's Gains from Sales and Divestitures peaked at $974,000 during FY2021, and registered a low of $55,000 during FY2020.
  • Its 3-year average for Gains from Sales and Divestitures is $503,333, with a median of $481,000 in 2022.
  • In the last 5 years, Legend Biotech's Gains from Sales and Divestitures soared by 1,670.91% in 2021 and then plummeted by 50.62% in 2022.
  • Over the past 3 years, Legend Biotech's Gains from Sales and Divestitures (Yearly) stood at $55,000 in 2020, then skyrocketed by 1,670.91% to $974,000 in 2021, then slumped by 50.62% to $481,000 in 2022.